Literature DB >> 31907181

Relationship between Vancomycin MIC and Virulence Gene Expression in Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus Strains Isolated from Left-Sided Endocarditis.

Juan M Pericàs1,2, Carlos Cervera3, Cristina Garcia-de-la-Mària2, Batu K Sharma-Kuinkel4, Rachelle Gonzales5,6, Asunción Moreno2, Manel Almela2, Carlos Falces2, Eduard Quintana2, David Fuster2, Francesc Marco2,7, Arnold S Bayer5,6, Vance G Fowler4, José M Miró8.   

Abstract

Higher vancomycin MICs have been associated with more complicated courses and higher mortality rates in patients with Staphylococcus aureus bacteremia and infective endocarditis (IE). The aim of this study was to investigate whether the strains belonging to the cohort of 93 patients from a previously published study in which patients with strains with vancomycin MICs of ≥1.5 μg/ml presented higher mortality rates and systemic emboli than patients with strains with vancomycin MICs of <1.5 μg/ml had specific patterns of virulence factors, clonal complex (CC) types, or the ability to form biofilms. Vancomycin MICs were determined by Etest, and the isolates underwent spa typing to infer the CC, biofilm studies, a thrombin-induced platelet microbicidal assay, and multiplex PCR for the presence of virulence genes. We found no differences in genes encoding adhesins, toxins, or other putative virulence genes according to the vancomycin MIC group. CC30, CC34, and CC45 represented nearly half of the isolates, and there was no association with the vancomycin MIC. agr subgroups I and III predominated, with no association with the vancomycin MIC. Isolates with higher vancomycin MICs exhibited a poorer ability to form biofilms with and without the presence of vancomycin (2.03 versus 2.48 [P < 0.001], respectively, for isolates with higher vancomycin MICs and 2.60 versus 2.87 [P = 0.022], respectively, for isolates with lower vancomycin MICs). In the multivariable analysis, efb and V8 were risk factors for major emboli (adjusted odds ratio [aOR] = 7.5 and 95% confidence interval [CI] = 1.2 to 46.6 for efb, and aOR = 3.9 and 95% CI = 1.1 to 14.1 for V8), whereas no genotypic predictors of in-hospital mortality were found. No clear associations between genes encoding virulence factors, agr type, clonal complexes, mortality, and major embolic events according to vancomycin MIC group were found.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcus aureus; agr; biofilm; clonal complex; emboli; endocarditis; mortality; prognosis; vancomycin MIC; virulence factors

Year:  2020        PMID: 31907181      PMCID: PMC7038266          DOI: 10.1128/AAC.01579-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Relationship between agr dysfunction and reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus causing bacteraemia.

Authors:  Esther Viedma; Francisca Sanz; M Angeles Orellana; Rafael San Juan; Jose Maria Aguado; Joaquín R Otero; Fernando Chaves
Journal:  J Antimicrob Chemother       Date:  2013-08-24       Impact factor: 5.790

3.  Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?

Authors:  L E López-Cortés; C Velasco; P Retamar; M D del Toro; J Gálvez-Acebal; M de Cueto; I García-Luque; F J Caballero; A Pascual; J Rodríguez-Baño
Journal:  J Antimicrob Chemother       Date:  2015-05-28       Impact factor: 5.790

Review 4.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

5.  Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study.

Authors:  Franck Thuny; Giovanni Di Salvo; Giovanni Disalvo; Olivier Belliard; Jean-François Avierinos; Valeria Pergola; Valerie Rosenberg; Jean-Paul Casalta; Joanny Gouvernet; Geneviève Derumeaux; Diana Iarussi; Pierre Ambrosi; Raffaele Calabró; Raffaello Calabro; Alberto Riberi; Frédéric Collart; Dominique Metras; Hubert Lepidi; Didier Raoult; Jean-Robert Harle; Pierre-Jean Weiller; Ariel Cohen; Gilbert Habib
Journal:  Circulation       Date:  2005-06-27       Impact factor: 29.690

6.  Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein.

Authors:  M R Yeaman; S M Puentes; D C Norman; A S Bayer
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Authors:  David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell
Journal:  Arch Intern Med       Date:  2009-03-09

8.  Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates.

Authors:  Natasha E Holmes; John D Turnidge; Wendy J Munckhof; J Owen Robinson; Tony M Korman; Matthew V N O'Sullivan; Tara L Anderson; Sally A Roberts; Sanchia J C Warren; Geoffrey W Coombs; Hui-Leen Tan; Wei Gao; Paul D R Johnson; Benjamin P Howden
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

9.  Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus binds to platelets and inhibits platelet aggregation.

Authors:  Oonagh Shannon; Jan-Ingmar Flock
Journal:  Thromb Haemost       Date:  2004-04       Impact factor: 5.249

10.  Extracellular Fibrinogen-binding Protein (Efb) from Staphylococcus aureus Inhibits the Formation of Platelet-Leukocyte Complexes.

Authors:  Mareike G Posner; Abhishek Upadhyay; Aisha Alsheikh Abubaker; Tiago M Fortunato; Dina Vara; Ilaria Canobbio; Stefan Bagby; Giordano Pula
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

View more
  1 in total

1.  Effect of the vancomycin minimum inhibitory concentration on clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.

Authors:  Changcheng Shi; Jian Ye; Renjie Xu; Weizhong Jin; Shuang Xu; Fei Teng; Nengming Lin
Journal:  BMJ Open       Date:  2021-01-15       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.